Fatty acid analogue N-arachidonoyl taurine restores function of IKs channels with diverse long QT mutations

Sara I. Liin, Johan E. Larsson, Rene Barro, Bo Hjorth Bentzen, H. Peter Larson

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

About 300 loss-of-function mutations in the IKs channel have been identified in patients with Long QT syndrome and cardiac arrhythmia. How specific mutations cause arrhythmia is largely unknown and there are no approved IKs channel activators for treatment of these arrhythmias. We find that several Long QT syndrome-associated IKs channel mutations shift channel voltage dependence and accelerate channel closing. Voltage-clamp fluorometry experiments and kinetic modeling suggest that similar mutation-induced alterations in IKs channel currents may be caused by different molecular mechanisms. Finally, we find that the fatty acid analogue N-arachidonoyl taurine restores channel gating of many different mutant channels, even though the mutations are in different domains of the IKs channel and affect the channel by different molecular mechanisms. N-arachidonoyl taurine is therefore an interesting prototype compound that may inspire development of future IKs channel activators to treat Long QT syndrome caused by diverse IKs channel mutations.

Original languageEnglish (US)
Article numbere20272
JournaleLife
Volume5
Issue numberSeptember2016
DOIs
StatePublished - Sep 30 2016

Fingerprint

Taurine
Fatty Acids
Long QT Syndrome
Mutation
Clamping devices
Electric potential
Cardiac Arrhythmias
Kinetics
Fluorometry
Experiments

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

Fatty acid analogue N-arachidonoyl taurine restores function of IKs channels with diverse long QT mutations. / Liin, Sara I.; Larsson, Johan E.; Barro, Rene; Bentzen, Bo Hjorth; Peter Larson, H.

In: eLife, Vol. 5, No. September2016, e20272, 30.09.2016.

Research output: Contribution to journalArticle

Liin, Sara I. ; Larsson, Johan E. ; Barro, Rene ; Bentzen, Bo Hjorth ; Peter Larson, H. / Fatty acid analogue N-arachidonoyl taurine restores function of IKs channels with diverse long QT mutations. In: eLife. 2016 ; Vol. 5, No. September2016.
@article{894e0c80b4314125a828c3deb84af83b,
title = "Fatty acid analogue N-arachidonoyl taurine restores function of IKs channels with diverse long QT mutations",
abstract = "About 300 loss-of-function mutations in the IKs channel have been identified in patients with Long QT syndrome and cardiac arrhythmia. How specific mutations cause arrhythmia is largely unknown and there are no approved IKs channel activators for treatment of these arrhythmias. We find that several Long QT syndrome-associated IKs channel mutations shift channel voltage dependence and accelerate channel closing. Voltage-clamp fluorometry experiments and kinetic modeling suggest that similar mutation-induced alterations in IKs channel currents may be caused by different molecular mechanisms. Finally, we find that the fatty acid analogue N-arachidonoyl taurine restores channel gating of many different mutant channels, even though the mutations are in different domains of the IKs channel and affect the channel by different molecular mechanisms. N-arachidonoyl taurine is therefore an interesting prototype compound that may inspire development of future IKs channel activators to treat Long QT syndrome caused by diverse IKs channel mutations.",
author = "Liin, {Sara I.} and Larsson, {Johan E.} and Rene Barro and Bentzen, {Bo Hjorth} and {Peter Larson}, H.",
year = "2016",
month = "9",
day = "30",
doi = "10.7554/eLife.20272",
language = "English (US)",
volume = "5",
journal = "eLife",
issn = "2050-084X",
publisher = "eLife Sciences Publications",
number = "September2016",

}

TY - JOUR

T1 - Fatty acid analogue N-arachidonoyl taurine restores function of IKs channels with diverse long QT mutations

AU - Liin, Sara I.

AU - Larsson, Johan E.

AU - Barro, Rene

AU - Bentzen, Bo Hjorth

AU - Peter Larson, H.

PY - 2016/9/30

Y1 - 2016/9/30

N2 - About 300 loss-of-function mutations in the IKs channel have been identified in patients with Long QT syndrome and cardiac arrhythmia. How specific mutations cause arrhythmia is largely unknown and there are no approved IKs channel activators for treatment of these arrhythmias. We find that several Long QT syndrome-associated IKs channel mutations shift channel voltage dependence and accelerate channel closing. Voltage-clamp fluorometry experiments and kinetic modeling suggest that similar mutation-induced alterations in IKs channel currents may be caused by different molecular mechanisms. Finally, we find that the fatty acid analogue N-arachidonoyl taurine restores channel gating of many different mutant channels, even though the mutations are in different domains of the IKs channel and affect the channel by different molecular mechanisms. N-arachidonoyl taurine is therefore an interesting prototype compound that may inspire development of future IKs channel activators to treat Long QT syndrome caused by diverse IKs channel mutations.

AB - About 300 loss-of-function mutations in the IKs channel have been identified in patients with Long QT syndrome and cardiac arrhythmia. How specific mutations cause arrhythmia is largely unknown and there are no approved IKs channel activators for treatment of these arrhythmias. We find that several Long QT syndrome-associated IKs channel mutations shift channel voltage dependence and accelerate channel closing. Voltage-clamp fluorometry experiments and kinetic modeling suggest that similar mutation-induced alterations in IKs channel currents may be caused by different molecular mechanisms. Finally, we find that the fatty acid analogue N-arachidonoyl taurine restores channel gating of many different mutant channels, even though the mutations are in different domains of the IKs channel and affect the channel by different molecular mechanisms. N-arachidonoyl taurine is therefore an interesting prototype compound that may inspire development of future IKs channel activators to treat Long QT syndrome caused by diverse IKs channel mutations.

UR - http://www.scopus.com/inward/record.url?scp=84992709131&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992709131&partnerID=8YFLogxK

U2 - 10.7554/eLife.20272

DO - 10.7554/eLife.20272

M3 - Article

C2 - 27690226

AN - SCOPUS:84992709131

VL - 5

JO - eLife

JF - eLife

SN - 2050-084X

IS - September2016

M1 - e20272

ER -